Cargando…

Next-generation ELISA diagnostic assay for Chagas Disease based on the combination of short peptidic epitopes

Chagas Disease, caused by the protozoan Trypanosoma cruzi, is a major health and economic problem in Latin America for which no vaccine or appropriate drugs for large-scale public health interventions are yet available. Accurate diagnosis is essential for the early identification and follow up of ve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mucci, Juan, Carmona, Santiago J., Volcovich, Romina, Altcheh, Jaime, Bracamonte, Estefanía, Marco, Jorge D., Nielsen, Morten, Buscaglia, Carlos A., Agüero, Fernán
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648266/ https://www.ncbi.nlm.nih.gov/pubmed/28991925 http://dx.doi.org/10.1371/journal.pntd.0005972

Ejemplares similares

Towards High-throughput Immunomics for Infectious Diseases: Use of Next-generation Peptide Microarrays for Rapid Discovery and Mapping of Antigenic Determinants
por: Carmona, Santiago J., et al.
Publicado: (2015)

Deep serological profiling of the Trypanosoma cruzi TSSA antigen reveals different epitopes and modes of recognition by Chagas disease patients
por: Romer, Guadalupe, et al.
Publicado: (2023)

The Trypanosoma cruzi Antigen and Epitope Atlas: antibody specificities in Chagas disease patients across the Americas
por: Ricci, Alejandro D., et al.
Publicado: (2023)

High-resolution profiling of linear B-cell epitopes from mucin-associated surface proteins (MASPs) of Trypanosoma cruzi during human infections
por: Durante, Ignacio M., et al.
Publicado: (2017)

Molecular and antigenic characterization of Trypanosoma cruzi TolT proteins
por: Lobo, Maite, et al.
Publicado: (2019)

Evaluation of the Chagas Western Blot IgG Assay for the Diagnosis of Chagas Disease
por: Brossas, Jean-Yves, et al.
Publicado: (2021)

Chagas disease-specific antigens: characterization of epitopes in CRA/FRA by synthetic peptide mapping and evaluation by ELISA-peptide assay
por: Bottino, Carolina G, et al.
Publicado: (2013)

ELISA F29 –A therapeutic efficacy biomarker in Chagas disease: Evaluation in pediatric patients treated with nifurtimox and followed for 4 years post-treatment
por: Rivero, Rocio, et al.
Publicado: (2023)

APRANK: Computational Prioritization of Antigenic Proteins and Peptides From Complete Pathogen Proteomes
por: Ricci, Alejandro D., et al.
Publicado: (2021)

Epitope Mapping of the Diphtheria Toxin and Development of an ELISA-Specific Diagnostic Assay
por: De-Simone, Salvatore Giovanni, et al.
Publicado: (2021)

TcSNP: a database of genetic variation in Trypanosoma cruzi
por: Ackermann, Alejandro A., et al.
Publicado: (2009)

Prevention of congenital Chagas through treatment of girls and women of childbearing age
por: Moscatelli, Guillermo, et al.
Publicado: (2015)

B-Cell Epitope Mapping of the Vibrio cholera Toxins A, B, and P and an ELISA Assay
por: De-Simone, Salvatore G., et al.
Publicado: (2022)

A Simple Strain Typing Assay for Trypanosoma cruzi: Discrimination of Major Evolutionary Lineages from a Single Amplification Product
por: Cosentino, Raul O., et al.
Publicado: (2012)

Characterization of Toxoplasma gondii subtelomeric-like regions: identification of a long-range compositional bias that is also associated with gene-poor regions
por: Dalmasso, María C, et al.
Publicado: (2014)

Biopharmaceutical Characteristics of Nifurtimox Tablets for Age‐ and Body Weight‐Adjusted Dosing in Patients With Chagas Disease
por: Stass, Heino, et al.
Publicado: (2020)

Longitudinal follow up of serological response in children treated for Chagas disease
por: Moscatelli, Guillermo, et al.
Publicado: (2019)

Genome-wide analysis of 3′-untranslated regions supports the existence of post-transcriptional regulons controlling gene expression in trypanosomes
por: De Gaudenzi, Javier G., et al.
Publicado: (2013)

Development and Application of an ELISA Assay Using Excretion/Secretion Proteins from Epimastigote Forms of T. cruzi (ESEA Antigens) for the Diagnosis of Chagas Disease
por: Berrizbeitia, Mariolga, et al.
Publicado: (2012)

Negligible exposure to nifurtimox through breast milk during maternal treatment for Chagas Disease
por: Moroni, Samanta, et al.
Publicado: (2019)

Diagnostic Accuracy of Two Molecular Tools for Diagnosis of Congenital Chagas Disease
por: Bisio, Margarita María Catalina, et al.
Publicado: (2021)

Angiostrongylus cantonensis an Atypical Presenilin: Epitope Mapping, Characterization, and Development of an ELISA Peptide Assay for Specific Diagnostic of Angiostrongyliasis
por: De-Simone, Salvatore G., et al.
Publicado: (2022)

Diagnostic Peptide Discovery: Prioritization of Pathogen Diagnostic Markers Using Multiple Features
por: Carmona, Santiago J., et al.
Publicado: (2012)

ELISA versus PCR for diagnosis of chronic Chagas disease: systematic review and meta-analysis
por: Brasil, Pedro EAA, et al.
Publicado: (2010)

In silico Design of an Epitope-Based Vaccine Ensemble for Chagas Disease
por: Michel-Todó, Lucas, et al.
Publicado: (2019)

Validation of Apolipoprotein A-1 and Fibronectin Fragments as Markers of Parasitological Cure for Congenital Chagas Disease in Children Treated With Benznidazole
por: Ruiz-Lancheros, Elizabeth, et al.
Publicado: (2018)

Accurate Real-Time PCR Strategy for Monitoring Bloodstream Parasitic Loads in Chagas Disease Patients
por: Duffy, Tomas, et al.
Publicado: (2009)

Pharmacokinetic and pharmacodynamic responses in adult patients with Chagas disease treated with a new formulation of benznidazole
por: Fernández, Marisa Liliana, et al.
Publicado: (2016)

Rapid diagnostic tests and ELISA for diagnosing chronic Chagas disease: Systematic revision and meta-analysis
por: Suescún-Carrero, Sandra Helena, et al.
Publicado: (2022)

Conformation-stabilizing ELISA and cell-based assays reveal patient subgroups targeting three different epitopes of AGO1 antibodies
por: Moritz, Christian P., et al.
Publicado: (2022)

Corrigendum: In silico Design of an Epitope-Based Vaccine Ensemble for Chagas Disease
por: Michel-Todó, Lucas, et al.
Publicado: (2020)

Urban Chagas disease in children and women in primary care centres in Buenos Aires, Argentina
por: Moscatelli, Guillermo, et al.
Publicado: (2015)

ELISA for Determination of Human Growth Hormone: Recognition of Helix 4 Epitopes
por: Moura, Juliana F., et al.
Publicado: (2004)

Population Pharmacokinetic Study of Benznidazole in Pediatric Chagas Disease Suggests Efficacy despite Lower Plasma Concentrations than in Adults
por: Altcheh, Jaime, et al.
Publicado: (2014)

Efficacy and Safety of Nifurtimox in Pediatric Patients with Chagas Disease: Results at 4-Year Follow-Up in a Prospective, Historically Controlled Study (CHICO SECURE)
por: Altcheh, Jaime, et al.
Publicado: (2023)

Long-term cardiology outcomes in children after early treatment for Chagas disease, an observational study
por: González, Nicolás Leonel, et al.
Publicado: (2022)

Current Advances in Nanotechnology for the Next Generation of Sequencing (NGS)
por: Bracamonte, Angel Guillermo
Publicado: (2023)

Effectiveness of Nifurtimox in the Treatment of Chagas Disease: a Long-Term Retrospective Cohort Study in Children and Adults
por: Falk, N., et al.
Publicado: (2022)

Congenital Chagas disease: Updated recommendations for prevention, diagnosis, treatment, and follow-up of newborns and siblings, girls, women of childbearing age, and pregnant women
por: Carlier, Yves, et al.
Publicado: (2019)

Determination of Cutoff of ELISA and Immunofluorescence Assay for Scrub Typhus
por: Gupta, Nitin, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3m05imdf5b9mf52f132tsdurno